Comparative assessment of α-amylase and α-glucosidase inhibition and in vitro antioxidant capacity of Garcinia schomburgkiana bark, fruit, and leaf extracts
Sunan Jaisamut, Boonyadist Vongsak
Pharmaceutical Innovations of Natural Products Unit, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi 20131, Thailand
|Date of Submission||28-Sep-2020|
|Date of Decision||02-Mar-2021|
|Date of Acceptance||22-Apr-2021|
|Date of Web Publication||11-Nov-2021|
Pharmaceutical Innovations of Natural Products Unit, Faculty of Pharmaceutical Sciences, Burapha University, Long Had Bangsaen Road, Tambon Saen Suk, Chonburi 20131
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Garcinia schomburgkiana is a conventionally used as an herb for the treatment of diabetes, coughs, and menstrual disturbances. Objectives: The study was to examine in vitro antioxidant potentials and inhibitory effect against α-amylase and α-glucosidase of the bark, fruit, and leaf extracts of G. schomburgkiana using different traditional extraction methods and investigate the bioactive compound using spectroscopic and chromatographic techniques. Materials and Methods: The extracts were prepared by maceration with 80% ethanol and decoction with distilled water. The anti-free radical activities of the extracts were tested through decolorization of 2,2-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), and lipid peroxidation assays. The active compound was elucidated and quantified. Results: The ethanolic bark extract displayed the highest activities of DPPH, ABTS, lipid peroxidation, α-glucosidase, and α-amylase inhibition assays with EC50 values of 28.96 ± 1.62, 9.79 ± 0.14, 574.89 ± 14.68, 20.40 ± 1.33 and 2.81 ± 0.43 μg/mL, respectively. Thus, the ethanolic bark extract was selected to assess the bioactive compound by bioactivity-guided isolation. The active biflavonoid, named morelloflavone, was isolated and elucidated. Morelloflavone exhibited high activities comparable with positive controls (ascorbic acid and acarbose). Moreover, the content of morelloflavone from different extracts was analyzed by high-performance liquid chromatography. The bark maceration with ethanol yielded the highest contents of morelloflavone. Conclusion: The bark ethanolic extract of G. schomburgkiana has more potentials than other extracts. The isolated compound demonstrated the strong activities and could be the alternative source of natural antioxidants and α-amylase and α-glucosidase inhibitor.
Keywords: Antioxidant, Garcinia schomburgkiana, morelloflavone, α-amylase, α-glucosidase
|How to cite this article:|
Jaisamut S, Vongsak B. Comparative assessment of α-amylase and α-glucosidase inhibition and in vitro antioxidant capacity of Garcinia schomburgkiana bark, fruit, and leaf extracts. Phcog Mag 2021;17:445-50
|How to cite this URL:|
Jaisamut S, Vongsak B. Comparative assessment of α-amylase and α-glucosidase inhibition and in vitro antioxidant capacity of Garcinia schomburgkiana bark, fruit, and leaf extracts. Phcog Mag [serial online] 2021 [cited 2021 Dec 1];17:445-50. Available from: http://www.phcog.com/text.asp?2021/17/75/445/330215
- The optimum extraction method of Garcinia schomburgkiana extracts was determined
- Morelloflavone from G. schomburgkiana extract was identified as a bioactive compound
- Morelloflavone could be used as a marker for G. schomburgkiana extract standardization.
Abbreviations used: DPPH: decolorization of 2,2-diphenyl-2-picrylhydrazyl; ABTS: 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid); FRAP: Ferric reducing antioxidant power; EC50: 50% effective concentration; HPLC: High-performance liquid chromatography; UV: Ultraviolet–visible spectrophotometer; IR: Infrared spectroscopy; MS: mass spectrometer; NMR: Nuclear Magnetic Resonance; pNPG: p-nitrophenyl β-D-glucopyranoside; DAD: Diode array detector; LSD: Least significant difference; TPC: Total phenolic contents; EBM: Ethanolic bark extract by maceration; ELM: Ethanolic leaf extract by maceration; ABD: Aqueous bark extract by decoction; EFM: Ethanolic fruit extract by maceration; AFD: Aqueous fruit extract by decoction; ALD: Aqueous leaf extract by decoction; GAE: galic acid equivalent.
| Introduction|| |
Diabetes mellitus is a complex chronic disease and a wild-growing medical problem over the globe in developing and developed countries. Diabetes type 2 diabetes is the most common type which is the seventh leading cause of death worldwide. Increased insulin resistance and impaired insulin secretion are the key pathophysiological factors of type 2 diabetes that cause post-prandial hyperglycemia. The long-term hyperglycemia increases oxidative stress and leads to numerous degenerative diseases such as cardiovascular disease, peripheral neuropathy, and nephropathy. α-amylase and α-glucosidase are carbohydrate digestive enzymes in human body of which directly related to the postprandial glycemic level. The inhibition of these enzymes can reduce and delay the formation of glucose to be absorbed into blood circular and avoiding of hyperglycemia. Although the clinical glucosidase inhibitors such as voglibose, miglitol, and acarbose can decrease postprandial hyperglycemia, the adverse effects of these synthetic drugs such as flatulence, diarrhea, and abdominal discomfort can limit patient compliance. Natural products for dealing of postprandial hyperglycemia and antioxidant from plants have become an attractive approach due to their low cost, safety, and fewer side effects.,
The genus Garcinia in the family Clusiaceae native to America, Africa, and Asia has been recognized as a rich source of numerous biological active constituents., Garcinia schomburgkiana Pierre is a medium evergreen tree locally known as Ma-dan, which is widely distributed in Southeast Asia. In folk medicine, this plant is used for the cure of cough, diabetes, and menstrual disturbances. The pharmacological studies on G. schomburgkiana extracts have revealed the antimalarial activity and cytotoxicity against cancer cell lines. In addition, phytochemical constituents of G. schomburgkiana have displayed the presence of benzophenones, bioflavonoids, biphenyl derivatives, and xanthones.,,
The aim of this study was to analyze α-glucosidase and α-amylase inhibitory activities including antioxidant activities performed by decolorization of 2,2-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), lipid peroxidation assay, and total phenolic contents (TPC) from bark, fruit, and leaf of G. schomburgkiana extracts using maceration with 80% ethanol and decoction with distilled water techniques. The extract owning the best α-glycosidase inhibition was further separated and purified through silica gel column and preparative thin-layer chromatography. The pure constituent was structurally characterized using infrared spectroscopy, mass spectrometry, and nuclear magnetic resonance to discover natural active compounds. The content of the bioactive component was also determined by high-performance liquid chromatography (HPLC).
| Materials and Methods|| |
General equipment and chemicals
Analytical grade solvents for extraction and isolation were purchased from Labscan Asia Co., Thailand, and high-purity chemicals were purchased from Sigma/Aldrich, USA. Column chromatography isolation and purification were done using silica gel 60 (0.040–0.063 mm Scharlau, Spain). For compound detection, pre-coated silica gel plates were operated (Merck silica gel 60 GF254, Germany). Preparative thin-layer chromatography was carried on precoated silica gel G 1000 μm (Analtech Inc., Delaware, USA). Ultraviolet (UV), infrared spectroscopy (IR), mass spectrometer (MS), and nuclear magnetic resonance (NMR) spectra were obtained on Shimadzu photodiode array detector (Shimadzu, Japan), Frontier FT-IR spectrometer (Perkin Elmer Ltd., UK), MICROTOF benchtop ESI-TOF-MS (Bruker Daltonics, Germany), and Avance III HD 400 (Bruker, MA, USA), respectively.
G. schomburgkiana (bark, leaves, and fruits) were collected from Phak Hai district, Ayutthaya Province, in November 2018. The species was identified by a taxonomist, Dr. Chakkrapong Rattamanee and the voucher specimen (GS20181101) was deposited at Faculty of Pharmaceutical Sciences, Burapha University. The bark, leaves, and fruits of G. schomburgkiana were air in a hot air oven (Memmert, Germany) at 50°C and then was powdered pass through a 0.5-mm sieve separately.
For maceration, the dried powder of bark, leaves, and fruits was set separately in an Erlenmeyer flask and extracted with 80% ethanol (1:20, w/v) for 72 h at 30°C with intermittent shaking. For decoction, the dried powder of bark, leaves, and fruits was also set in an Erlenmeyer flask and boiled with distilled water (1:20, w/v) at 80°C for 15 min and then filtered. The residue of each method was re-extracted again. After that, the pooled extract was separately filtered and dried using a vacuum evaporator (Buchi, Switzerland) under reduced pressure at 50°C.
Total phenolic content
Total phenolic content was evaluated by the Folin–Ciocalteu colorimetric method. Total phenolics of triplicate analyses were showed as gallic acid equivalent (mg GAE)/g extract and present on mean ± standard deviation.
Decolorization of 2,2-diphenyl-2-picryl hydrazyl free radical scavenging activity
The hydrogen donating capability of the crude extracts and pure compound from G. schomburgkiana were determined by DPPH. Ascorbic acid and quercetin were used as standards at concentrations similar to those of morelloflavone (25, 12.5, 6.25, 3.125, 1.56, 0.78, and 0.39 μg/mL) and were treated under the same condition as the samples (625, 500, 250, 125, 62.5, 31.25, 15.63, 7.81, and 3.91 μg/mL). The absorbance was detected at 517 nm. The results were reported from EC50 value, which is the concentration of the antioxidant agent that is essential to scavenge 50%t of DDPH in the test sample.
2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) radical cation scavenging activity
The antioxidant capacity assay was carried out using the ABTS radical cation capturing method. Ascorbic acid and quercetin were used as standards at concentrations similar to those of morelloflavone (25, 12.5, 6.25, 3.125, 1.56, 0.78, and 0.39 μg/mL) and were treated under the same condition as the samples (500, 250, 125, 62.5, 31.25, 15.63, 7.81, and 3.91 μg/mL). The absorbance was detected at 734 nm. The results were calculated as EC50 value which means the minimum concentration of antioxidant agent required to trap 50% of radicals.
Lipid peroxidation inhibitory activity
Lipid peroxidation assay was achieved according to the method of Srinivasan et al. Briefly, the different concentrations of sample or control (100 μL) were added to 900 μL egg lectin mixture. Quercetin was used as the standard at concentrations similar to those of morelloflavone (125, 62.5, 31.25, 15.63, 7.81, and 3.91 μg/mL) and was treated under the same condition as the samples (1000, 500, 250, 125, 62.5, and 31.25 μg/mL). Lipid peroxidation was started by adding ferric chloride (400 mM, 40 μL) and ascorbic acid (200 mM, 40 μL) and incubate for 60 min at 37°C. After that, 2 mL of 0.25N HCl containing 0.375% thiobarbituric acid and 15% trichloroacetic acid was added to stop the reaction and boiled for 15 min. After chilling, the combination was centrifuged at 3000 g for 5 min and the absorbance of the supernatant was evaluated at 532 nm. The results were reported as EC50 value.
Enzyme inhibitory effects
α-glucosidase inhibitory activity
The activity was investigated using p-nitrophenyl β-D-glucopyranoside (pNPG) by the method of Vongsak et al. In brief, 50 μL of different concentrations of samples and control was mixed with 50 μL of 0.1 M sodium phosphate buffer (pH 7.0) and 2 units/mL of 50 μL α-glucosidase and pre-incubated for 10 min at 37°C. Then, 50 μL of 20 mM pNPG was added to initiate the reaction. After incubation for 30 min at 37°C, the absorbance was determined at 405 nm and calculated as EC50 value.
α-amylase inhibitory activity
The inhibitory activity assay was carried out from the method of Thengyai et al. In short, 0.2 mL of 50 mM Tris-HCl buffer (pH 6.9) consisting of 10 mM CaCl2 was added starch azure (2 mg) and boiled for 10 min. Different concentrations of sample or control (0.2 mL) were added in 0.1 mL of α-amylase (2 units/mL) in 20 mM phosphate buffer (pH 6.9) containing 6.7 mM NaCl after pre-incubated at 37°C for 5 min. The reaction was kept at 37°C for 10 min and added 50% acetic acid (0.5 mL) to stop the reaction. After cooling, the combination was centrifuged at 3000 g for 5 min and the absorbance of the supernatant was evaluated at 595 nm. The results were reported as EC50 value.
Isolation of active compound
Crude extract exhibited the strongest antioxidant and enzyme inhibitory effects that were obtained by extracting dried powder of bark with 80% ethanol. The extract (10 g) was subjected to vacuum chromatography using silica gel as stationary phase and fractionated with hexane, dichloromethane, ethyl acetate, acetone, and methanol. The ethyl acetate fraction (2.50 g) displayed the highest antioxidant and enzyme inhibitory effects. This fraction was eluted with gradient hexane: ethyl acetate (50:50–0:100) by silica column chromatography (70 cm × 2.5 cm) to be collected and combined into 23 fractions. Subfraction 20 (300 mg) expressed the strongest activities and further separately purified through preparative thin-layer chromatography. Using a silica gel plate (Analtech Inc., Delaware, USA), the subfraction was eluted with hexane: ethyl acetate: methanol (3:6.5:0.5) to obtain pure compound 30 mg.
High-performance liquid chromatography
The pure compound, morelloflavone (purity ≥98%), was isolated from bark extract of G. schomburgkiana. Each standard solution was diluted into eight concentrations (200, 100, 50, 25 12.5, 6.25, 3.125, and 1.56 μg/mL) to achieve a calibration curve. Quantitative investigation of the active component was completed using the HPLC technique on a Shimadzu (Shimadzu, Kyoto, Japan) equipped with a SIL-20A HT autosampler, CT0-10ASvp column oven, LC-20AD pump, and SPD-M20A diode array detector (DAD). An ACE5 C18 column (150 mm × 4.6 mm i.d., 5 μm) with a C18 guard column (Phenomenex, California, USA) was also utilized. The elution was done using 0.5% formic acid in water (solvent A) and methanol (solvent B) as a mobile phase with the subsequent isocratic (50:50) for 20 min. The flow rate was fixed at 1.0 ml/mL with a measured temperature of 25°C. Each extract was dissolved in methanol to obtain a concentration of 1 mg/mL and filtered over a 0.2 mm nylon membrane filter. The DAD detector was examined at 290 nm and the injection amount for each sample and standard was 10 μL.
The results were described as mean ± standard deviation (n = 3). The average content of total phenolics and EC50 of the extracts carried on the different assays were statistically examined using one-way ANOVA with the least significant difference by SPSS (IBM Corp., NY, USA) for Windows 21.0. P < 0.05 was specified as a statistically significant difference.
| Results|| |
[Table 1] demonstrating the values of TPC and biological activities of six G. schomburgkiana extracts displays that the ethanolic bark extract by maceration (EBM) gave the highest amount of TPC with 222.18 ± 3.53 mg GAE/g extract. In addition, the ethanolic leaf extract by maceration (ELM) exhibited the second-high amount of TPC with 191.67 ± 5.95 mg GAE/g extract, while the aqueous decoction of bark, leaves, and fruits showed lower TPC with 133.76 ± 10.17, 102.26 ± 29.96, and 130.23 ± 34.92 mg GAE/g extract. For biological activities, the EBM also exhibited the strongest DPPH, ABTS, lipid peroxidation, α-glucosidase, and α-amylase inhibitory activities with value of EC50 24.75 ± 1.69 μg/mL, 11.14 ± 0.22 μg/mL, 769.07 ± 36.01 μg/mL, 2.91 ± 0.09 μg/mL, and 8.17 ± 0.93 μg/mL, respectively. The EC50 values of DPPH, ABTS radical scavenging activities, α-glucosidase and α-amylase inhibitory activities of ELM extract were the second-high with values of 51.51 ± 2.15, 13.65 ± 0.04, 856.61 ± 8.31, 8.31 ± 0.36, and 22.10 ± 0.18, respectively. The aqueous leaf extract by decoction (ALD) provided the lowest DPPH, ABTS, lipid peroxidation, and α-glucosidase and α-amylase inhibitory activities with value of EC50 535.99 ± 37.02, 225.63 ± 4.26 μg/mL, >1000, 48.21 ± 0.42, and >1000 μg/mL, respectively. In addition, the ethanolic extract by maceration method expressed the stronger biological activities than aqueous extract by decoction method for bark, fruits, and leaves of G. schomburgkiana.
|Table 1: Antioxidation activity and α-amylase and α-glucosidase inhibition activities of Garcinia schomburgkiana extracts using different plant part and extraction techniques and the active compounds|
Click here to view
Due to the maximum biological activities, EBM was selected to separate and elucidate the bioactive constituent by α-glucosidase inhibitory activity-guided isolation. The crude extract was subjected to column chromatographic separation and preparative thin layer chromatography to acquire morelloflavone [Figure 1]. The substance was obtained as a yellow solid, HREIMS: calcd for C30H20O11, m/z 556.4732 [M] +, found 557.1083. UV (CH3OH, 0.1%) λmax/nm: 346, 289. IR: 3326, 1643, 1604, 1259, 1167, 837 cm − 1. 1H NMR (CD3OD, 400 MHz, δ-ppm): δ 5.76 (1H, d, J = 12 Hz, H-2), 4.83 (1H, d, J = 12 Hz, H-3), 5.98 (1H, d, J = 1.6 Hz, H-6), 6.00 (1H, d, J = 1.6, H-8), 7.12 (2H, d, J = 8.4 Hz, H-2'), 6.43 (2H, d, J = 8.4 Hz, H-3'), 6.43 (2H, d, J = 8.4 Hz, H-5'), 7.12 (2H, d, J = 8.4 Hz, H-6'), 6.41 (1H, s, H-3''), 6.27 (1H, s, H-6''), 7.35 (1H, d, J = 2.0, H-2'''), 6.90 (1H, d, J = 8.4, H-5'''), 7.29 (1H, dd, J = 8.4, 2.0, H-6'''). 13C NMR (100 MHz, δ-ppm): δ 81.3 (C-2), 49.5 (C-3), 196.0 (C-4), 164.4 (C-5), 96.0 (C-6), 166.8 (C-7), 95.0 (C-8), 163.4 (C-9), 102.0 (C-10), 129.1 (C-1'), 127.9 (C-2'), 114.2 (C-3'), 157.5 (C-4'), 114.2 (C-5'), 127.9 (C-6'), 164.4 (C-2''), 102.0 (C-3''), 182.4 (C-4''), 161.2 (C-5''), 98.4 (C-6''), 161.9 (C-7''), 100.6 (C-8''), 157.2 (C-9''), 103.6 (C-10''), 122.1 (C-1'''), 112.8 (C-2'''), 145.4 (C-3'''), 149.6 (C-4'''), 115.5 (C-5'''), and 119.2 (C-6''') [Table 2]. The isolated compound, morelloflavone, demonstrated the strong DPPH, ABTS, lipid peroxidation, α-amylase, and α-glucosidase inhibitory activities comparable with positive controls (ascorbic acid, quercetin, and acarbose) with EC50 values of 3.22 ± 0.24, 6.46 ± 0.09, 9.54 ± 0.19, 6.57 ± 0.70, and 0.72 ± 0.07 μg/mL, respectively [Table 1]. The amount of morelloflavone from different extraction was in the range of not detected to 85.37 ± 2.96 mg/g extract. In the ethanol extract of bark, fruit and leaf, the content of morelloflavone was 85.37 ± 2.96, 5.13 ± 0.04, and undetectable, respectively [Figure 2], while the decoction method of bark, fruit, and leaf cannot detect morelloflavone content.
|Figure 1: Structure of morelloflavone, an active compound of Garcinia schomburgkiana|
Click here to view
|Table 2: 1H (400 MHz) and 13C (100 MHz) nuclear magnetic resonance spectroscopic data of isolated compound and reference compound|
Click here to view
|Figure 2: High-performance liquid chromatography chromatograms of morelloflavone (a) and ethanol extracts of bark (b), fruits (c) and leaf (d) of Garcinia schomburgkiana at 290 nm|
Click here to view
| Discussion|| |
The genus Garcinia contains a diversity of pharmacologically active natural constituents such as flavonoids, terpenoids, xanthones, and benzophenones., In this study, the free radical-scavenging and antidiabetic activities of G. schomburgkiana were established. The results [Table 1] demonstrated that the bark of ethanolic extract exhibited the greatest ability to scavenge DPPH and ABTS radicals, having approximately fourfold greater activity than the aqueous extracts. The free radical-scavenging capacity of the extracts decreased in the order of EBM > aqueous bark extract by decoction > ELM > ethanolic fruit extract by maceration > aqueous fruit extract by decoction > ALD. These results illustrated the promising antioxidant effects of the plant, and these effects are influenced by the solubility and polarity of the active compound. The slightly different results between TPC and antioxidant activity are probably attributable to synergistic effects and the complexity of the chemical structures. Thus, the activity of the phenolic compounds might depend on both the active constituents and other active phytochemicals. In addition, Meechai et al. reported that the extracts of G. schomburgkiana obtained using organic solvents such as acetone, dichloromethane, and methanol have strong antioxidant activities and high TPC. However, in traditional medicine, G. schomburgkiana was prepared via maceration with ethanol or decoction with water, as applied in this study. The results illustrated that ethanolic extraction provided higher TPC than obtained using organic solvents.
Regarding enzyme inhibition, agents that inhibit α-amylase and α-glucosidase play important roles in deceasing hyperglycemia, which is one of the factors causing oxidative stress and type 2 diabetes. Garcinia spp., such as G. gracilis, G. mangostana, and G. oblongifolia, also inhibited these enzymes, and the active compounds have been reported as phenolics and flavonoids.,,, All extracts exerted concentration-dependent inhibitory activity. In particular, the ethanolic extracts of bark, fruit, and leaves inhibited α-amylase and α-glucosidase activities at all analyzed concentrations. Meanwhile, the aqueous extracts did not inhibit enzyme activity at concentrations of below 1.56 μg/mL. Concentrations of higher than 1000 μg/mL were not considered because absorbance signals exceeded the linear range. These results indicated that the solvent used for extraction affects the enzyme-inhibitory activity of G. schomburgkiana, consistent with a previous report observing a comparable phenomenon for Pluchea indica extract. Besides, the bark extract exhibited a stronger α-amylase and α-glucosidase inhibitory effect than the leaf and fruit extracts. Comparing the inhibition values, the extracts displayed weaker α-amylase inhibitory activity than α-glucosidase inhibitory activity. Researchers previously hypothesized that effective beneficial constituents for controlling postprandial hyperglycemia with fewer adverse effects than acarbose (an antidiabetic medicine) have weaker α-amylase inhibitory activity than α-glucosidase inhibitory activity.
EBM most strongly inhibited α-amylase and α-glucosidase activities, and its EC50 values were relatively higher than those of acarbose. This phenomenon suggests that a large amount of the bioactive substance was present in this sample. Thus, this crude extract was chosen to clarify the active compound. Morelloflavone was identified as the active compound, and it displayed potent antioxidant and α-amylase and α-glucosidase inhibitory activities. Thus, morelloflavone could be used as a marker to standardize bioactivity. Using HPLC analysis, the highest content of morelloflavone was found in the ethanolic bark extract. In a previous study, several bioflavonoids and xanthones with antioxidant activity and cytotoxicity against cancer cell lines were isolated from G. schomburgkiana.,,, Nevertheless, no prior report described the active constituent of G. schomburgkiana extract or its antidiabetic activity. Plants from the same genus have been studied for α-amylase and α-glucosidase inhibitory activity. For example, cowanin and cowanol from the twig extract of G. oblongifolia inhibited α-glucosidase activities with IC50 values of 10.7 ± 1.7 and 28.0 ± 11.8 μM, respectively, whereas morelloflavone inhibited α-glucosidase activities with an IC50 of 1.29 ± 0.13 μM (48.21 ± 0.42 μg/mL). Although some other phytochemicals of G. schomburgkiana such as kaempferol, gentisein, and norathyriol may have slightly influenced the observed biological activity in a previous report, morelloflavone was a major active compound displaying strong activities using bioassay-guided isolation in this work. The gastrointestinal enzymes α-amylase and α-glucosidase were used to assess inhibitory activity in vitro as a comprehensive model for antidiabetic nutraceutical analysis to screen prospective inhibitors. Thus, EBM could represent a suitable alternative source of antidiabetic and antioxidant supplements, and morelloflavone could be the bioactive compound. In vivo studies will be essential for the clinical use of morelloflavone and EBM in the treatment of diabetes and associated maladies.
| Conclusion|| |
In this study, in vitro α-glucosidase and α-amylase inhibitory activity and antioxidant capacity of different plant parts and method of G. schomburgkiana that used as traditional antidiabetic treatment were compared. The EBM indicated the strongest activity and morelloflavone was isolated and identified as a bioactive substance by gastrointestinal enzymes inhibitory activity and antioxidant. Thus, the present work could endorse the traditional use of G. schomburgkiana to treat diabetes. EBM might be a more appropriate choice for development as a nutraceutical product and morelloflavone could be used as a marker for standardization.
The authors also would like to thank Pharmaceutical Innovations of Natural Products Unit, Faculty of Pharmaceutical Sciences, Burapha University, and the research grant of Faculty of Pharmaceutical Sciences, Burapha University (Grant no. RX2/2563).
Financial support and sponsorship
The study was supported by Burapha University.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Bacanli M, Dilsiz SA, Başaran N, Başaran AA. Effects of phytochemicals against diabetes. In: Toldrá F, editor. Advances in Food and Nutrition Research. Vol. 89., Ch. 5. United Kingdom: Academic Press; 2019. p. 209-38.
Ibrahim MT, Uzairu A, Shallangwa GA, Ibrahim A. In-silico
studies of some oxadiazoles derivatives as anti-diabetic compounds. J King Saud Univ Sci 2020;32:423-32.
Beidokhti MN, Jäger AK. Review of antidiabetic fruits, vegetables, beverages, oils and spices commonly consumed in the diet. J Ethnopharmacol 2017;201:26-41.
Vongsak B, Kongkiatpaiboon S, Jaisamut S, Konsap K. Comparison of active constituents, antioxidant capacity and α-glucosidase inhibition in Pluchea indica
leaf extracts at different maturity stages. Food Biosci 2018;25:68-73.
Thengyai S, Thiantongin P, Sontimuang C, Ovatlarnporn C, Puttarak P. α-Glucosidase and α-amylase inhibitory activities of medicinal plants in Thai antidiabetic recipes and bioactive compounds from Vitex glabrata
R. Br. stem bark. J Herb Med 2019;19:100302.
Ramirez C, Gil JH, Marín-Loaiza JC, Rojano B, Durango D. Chemical constituents and antioxidant activity of Garcinia madruno
(Kunth) Hammel. J King Saud Univ Sci 2019;31:1283-9.
Salleh WM, On S, Ahmad F, Sirat HM, Taher M, Sarker SD, Nahar L, et al.
A new xanthone and a new benzophenone from the roots of Garcinia hombroniana
. Phytochem Lett 2020;35:216-9.
Mungmee C, Sitthigool S, Buakeaw A, Suttisri R. A new biphenyl and other constituents from the wood of Garcinia schomburgkiana
. Nat Prod Res 2013;27:1949-55.
Sukandar ER, Siripong P, Khumkratok S, Tip-Pyang S. New depsidones and xanthone from the roots of Garcinia schomburgkiana
. Fitoterapia 2016;111:73-7.
Boonyong C, Pattamadilok C, Suttisri R, Jianmongkol S. Benzophenones and xanthone derivatives from Garcinia schomburgkiana
-induced P-glycoprotein overexpression in human colorectal Caco-2 cells via oxidative stress-mediated mechanisms. Phytomedicine 2017;27:8-14.
Kaennakam S, Mudsing K, Rassamee K, Siripong P, Tip-Pyang S. Two new xanthones and cytotoxicity from the bark of Garcinia schomburgkiana
. J Nat Med 2019;73:257-61.
Sato VH, Chewchinda S, Parichatikanond W, Vongsak B. In vitro
and in vivo
evidence of hypouricemic and anti-inflammatory activities of Maclura cochinchinensis
(Lour.) Corner heartwood extract. J Tradit Complement Med 2020;10:85-94.
Srinivasan R, Chandrasekar MJ, Nanjan MJ, Suresh B. Antioxidant activity of Caesalpinia digyna
root. J Ethnopharmacol 2007;113:284-91.
Vongsak B, Kongkiatpaiboon S, Jaisamut S, Machana S, Pattarapanich C. In vitro
alpha glucosidase inhibition and free-radical scavenging activity of propolis from Thai stingless bees in mangosteen orchard. Rev Bras Farmacogn 2015;25:445-50.
Aravind AP, Pandey R, Kumar B, Rameshkumar KB. Phytochemical investigation of the western Ghats endemic species Garcinia travancorica
Bedd. In: Rameshkumar KB, editor. Diversity of Garcinia
Species in the Western Ghats: Phytochemical Perspective. Ch. 4. India: Jawaharlal Nehru Tropical Botanic Garden and Research Institute; 2016. p. 87-100.
Sae-Lim P, Yuenyongsawad S, Panichayupakaranant P. Chamuangone-enriched Garcinia cowa
leaf extract with rice bran oil: Extraction and cytotoxic activity against cancer cells. Pharmacogn Mag 2019;15:183-8.
Munjal K, Ahmad S, Gupta A, Haye A, Amin S, Mir S, et al.
Polyphenol-enriched fraction and the compounds isolated from Garcinia indica
fruits ameliorate obesity through suppression of digestive enzymes and oxidative stress. Pharmacogn Mag 2020;16:236-45.
Babbar N, Oberoi HS, Sandhu SK, Bhargav VK. Influence of different solvents in extraction of phenolic compounds from vegetable residues and their evaluation as natural sources of antioxidants. J Food Sci Technol 2014;51:2568-75.
Sengul M, Yildiz H, Gungor N, Cetin B, Eser Z, Ercisli S. Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants. Pak J Pharm Sci 2009;22:102-6.
Meechai I, Phupong W, Chunglok W, Meepowpan P. Antioxidant properties and phytochemical contents of Garcinia schomburgkiana
pierre. J App Pharm Sci 2016;6:102-7.
Ryu HW, Cho JK, Curtis-Long MJ, Yuk HJ, Kim YS, Jung S, et al.
α-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana
. Phytochemistry 2011;72:2148-54.
Supasuteekul C, Nonthitipong W, Tadtong S, Likhitwitayawuid K, Tengamnuay P, Sritularak B. Antioxidant, DNA damage protective, neuroprotective and α-glucosidase inhibitory activities of a flavonoid glycoside from leaves of Garcinia gracilis
. Rev Bras Farmacogn 2016;26:312-20.
Trinh BT, Quach TT, Bui DN, Staerk D, Nguyen LD, Jäger AK. Xanthones from the twigs of Garcinia oblongifolia
and their antidiabetic activity. Fitoterapia 2017;118:126-31.
Ibrahim SR, Mohamed GA, Khayat MT, Ahmed S, Abo-Haded H, Alshali KZ, et al.
Mangostanaxanthone VIIII, a new xanthone from Garcinia mangostana
pericarps, α-amylase inhibitory activity and molecular docking studies. Rev Bras Farmacogn 2019;29:206-12.
Kongkiatpaiboon S, Chewchinda S, Vongsak B. Optimization of extraction method and HPLC analysis of six caffeoylquinic acids in Pluchea indica
leaves from different provenances in Thailand. Rev Bras Farmacogn 2018;28:145-50.
Kwon YI, Apostolidis E, Shetty K. Inhibitory potential of wine and tea against α-amylase and α-glucosidase for management of hyperglycemia linked to type 2 diabetes. J Food Biochem 2008;32:15-31.
Meechai I, Phupong W, Chunglok W, Meepowpan P. Anti-radical activities of xanthones and flavonoids from Garcinia schomburgkiana
. Int J Pharm 2016;8:235-8.
[Figure 1], [Figure 2]
[Table 1], [Table 2]